During the past decade, Sahlgrenska Academy conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sahlgrenska Academy" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials, followed by "Sahlgrenska University Hospital, Sweden" with 3 trials sponsored, "Göteborg University" with 2 trials sponsored, "St. James's Hospital, Ireland" with 2 trials sponsored and "Albireo" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sahlgrenska Academy" #1 collaborator was "Göteborg University" with 3 trials as a collaborator, "University College Dublin" with 2 trials as a collaborator, "University of Dublin, Trinity College" with 2 trials as a collaborator, "Albireo" with 1 trials as a collaborator and "Anglo Celtic Cooperative Oncology Group" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Sahlgrenska Academy" are "Esophageal Neoplasms" (2 trials), "Malnutrition" (2 trials), "Stomach Neoplasms" (2 trials), "Weight Loss" (2 trials) and "Acute Myeloid Leukemia" (1 trials). Many other conditions were trialed in "Sahlgrenska Academy" in a lesser frequency.

Most popular intervention types in "Sahlgrenska Academy" are "Drug" (9 trials), "Biological" (3 trials), "Device" (2 trials), "Dietary Supplement" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Octreotide" (2 trials), "Placebo" (2 trials), "conventional surgery" (2 trials), "cyclophosphamide" (2 trials) and "fluorouracil" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sahlgrenska Academy" are 12 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Sahlgrenska Academy". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Sahlgrenska Academy, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Sahlgrenska Academy, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".